home / stock / cydy / cydy news

CYDY News and Press, CytoDyn Inc From 03/05/21

Stock Information
Company Name: CytoDyn Inc
Stock Symbol: CYDY
Market: OTC
Website: cytodyn.com
Menu
CYDY CYDY Quote CYDY Short CYDY News CYDY Articles CYDY Message Board
Get CYDY Alerts

News, Short Squeeze, Breakout and More Instantly...
CYDY - CytoDyn to Hold Webcast on March 8 to Provide Overview of CD12 Trial Data and Regulatory Path Forward with the U.S., U.K., Canada, Philippines and Brazil

VANCOUVER, Washington, March 05, 2021 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY) , (“CytoDyn” or the “Company"), a late-stage biotechnology company developing Vyrologix™ (leronlimab-PRO 140), a CCR5 antagonist with the potential for multiple therapeutic ...
CYDY - CytoDyn's Phase 3 Trial Demonstrates Safety, a 24% Reduction in Mortality and Faster Hospital Discharge for Mechanically Ventilated Critically Ill COVID-19 Patients Treated with Leronlimab

VANCOUVER, Washington, March 05, 2021 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY) , (“CytoDyn” or the “Company"), a late-stage biotechnology company developing Vyrologix™ (leronlimab-PRO 140), a CCR5 antagonist with the potential for multiple therapeutic ...

CYDY - CytoDyn Files Form S-3 to Replace Expiring Shelf Registration Statement

VANCOUVER, Washington, March 03, 2021 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY) , (“CytoDyn” or the “Company"), a late-stage biotechnology company developing Vyrologix™ (leronlimab-PRO 140), a CCR5 antagonist with the potential for multiple therapeutic ...

CYDY - CytoDyn in discussions with regulators after CD12 data in COVID-19

CytoDyn (CYDY) announces that the CD12 COVID-19 trial data has been unblinded and the results will be reported when the Company has concluded its ongoing discussions with the regulatory agencies. CYDY expects to release CD12 data the complete results of its discussions with regulators in...
CYDY - CytoDyn in Discussions with U.S. FDA, MHRA and Health Canada After Unblinding its CD12 Trial Data for Severe-to-Critically Ill COVID-19 Patients

CytoDyn expects to release CD12 data and complete discussions with various regulatory agencies within 2 to 3 weeks VANCOUVER, Washington, Feb. 22, 2021 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY) , (“CytoDyn” or the “Company"), a late-stage biotechnolo...

CYDY - CytoDyn: Reliable In All The Wrong Places

CytoDyn is a little biotech that has worked diligently but unsuccessfully to develop a single therapy, variously named Pro 140, leronlimab, and Vyrologix. In development of this therapy, CytoDyn has cast its net far and wide both geographically and in terms of potential indications. ...

CYDY - Chiral Pharma Corp. to Assist Philippine Physicians Apply for Compassionate Special Permit (CSP) to Access CytoDyn's Leronlimab for COVID-19 Patients, as Philippines FDA Reviews Each Application for Approval to Sell Leronlimab for CSP Use

CytoDyn will dedicate at least 200,000 vials (100,000 doses) of leronlimab from its inventory to Chiral Pharma Corp. for potential sales in the Philippines VANCOUVER, Washington, Jan. 29, 2021 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY) , (“CytoDyn” or the &#...
CYDY - Studies Indicating T-Cells May Be Needed For Long-Term Protection From The SARS-Cov-2 Virus

Palm Beach, FL – January 28, 2021 – According to the National Institutes of Health (NIH), the tide in the global fight against COVID-19, the disease caused by the SARS-CoV-2 virus, may soon begin to turn. Last month, three pharmaceutical companies announced promising results f...

CYDY - CytoDyn And Humanigen: Ticking Time Bombs, Impending Results Likely To Fail

CytoDyn and Humanigen are running high-visibility trials focused on ameliorating COVID-19 acute inflammation. Acute inflammation plays a major role in the hospitalizations and deaths of patients with COVID-19. Despite monoclonal antibody drug approvals for 88 chronic inflammatory ...

CYDY - FDA Authorizes Monoclonal Antibodies for Treatment of COVID-19

Palm Beach, FL – January 21, 2021 – Most of the news on advances for Covid-19 tend to focus on vaccines, however treatments are just as important. While vaccines can stop people from contracting Covid and becoming seriously ill, treatments will still be needed for those who al...
Previous 10 Next 10